Skip to content
Sign in
SWC 2026 FinalistGrand Final: Lunch Block

TIBOK

Mauritian AI-native healthcare operating system — Eva assistant plus sourced clinical intelligence — sold pay-per-consultation and white-labelled to distributors.

Grand Baie, Mauritius, AfricaHealthTech, Primary care operating system (AI, RAG, EVA agent)
Stage
SeedAI at the core
Product
On the marketFirst customers
Funding raised
Undisclosedno funding
Founded
20251 years ago
Founders
1Dr
Global score
6.0Grade BRank 10 of 151

Overview

TIBOK is not a teleconsultation app: it is an AI-native healthcare operating system — one health ecosystem and one patient record, at home, at the practice, by video, at the clinic or hospital, at consultation points in pharmacies and labs, and in emergencies. Designed by a doctor around clinical reasoning: AI assists, the doctor keeps the decision.

How it works.

Everything runs through Eva, the AI assistant on WhatsApp, by phone (SIP trunk) or in the app: she welcomes every patient in their language (Kreol, French, English, Malagasy, Swahili, Arabic and many more), prepares the doctor's file, guides to the right care, coordinates consultations and tests, monitors every reading, reminds, alerts and calls back, and delivers prescriptions and results — or a nurse prepares the file instead.

My Medical Intelligence drafts the paperwork on 21,000+ authoritative references (ESC, ESH, ACC/AHA, HAS, NICE, ADA, WHO…), every suggestion sourced; the doctor reviews and signs, and signed documents are frozen, timestamped and fingerprinted.

Up to 8 consultations per hour per doctor, and thousands of calls handled at once.

Services on one platform. instant video consultation without appointment, appointments, specialists, second opinion, dermatology by photo, chronic care led by the doctor and monitored by Eva, nursing, prescriptions and sick notes, labs (including home sample collection) and radiology connected via HL7 v2 / FHIR R4, pharmacy and lab consultation points, connected devices (Apple Health, Android Health Connect, direct Bluetooth, or a simple photo of a screen), emergency handoff with the record following the patient, SilentCheck (22 questions, no blood test, biological age, built on Framingham, IDRS and SCORED) and MedicalCheck exams for insurers.

Who it is for. Clinics, hospitals, doctors, insurers, health centres, laboratories and pharmacies use it — or distribute it under their own brand, on their own WhatsApp and phone numbers, with one workspace per client (country, language, time zone).

Multi-country, multilingual, hosted on AWS in each market's region, SOC 2, AES-256, TLS 1.2+, compliance market by market, AI-model agnostic (Claude, GPT, Gemini, Mistral, Llama, DeepSeek or a local model).

Business model — public pricing, no commitment, pay as you go, three units of value, everything else included (no licence for hospitals, clinics, health centres or practices; lab, radiology and partner interconnection included): Eva Voice + My Medical Intelligence USD 2.60 per consultation; Eva Chat + My Medical Intelligence USD 1.20 per consultation; phone reception and switchboard USD 0.20 per minute; SilentCheck USD 2.40 by voice or USD 1.00 by message.

Volume tiers −20% from 5,000 and −30% from 20,000 consultations a month (distributor status). Prepaid credits adjusted monthly; telecom billed separately, WhatsApp at no extra cost; set-up on quotation.

Traction

First customers

Live in Mauritius — try Eva on WhatsApp at +230 5942 4894. First white-label distributor contract signed with C-Care Madagascar (19 November 2026), going live in January 2027 with its own Malagasy-speaking agent; white-label agreement with Médecin à Domicile in Mauritius.

Insurer agreements in Mauritius. SICOM contract signed and Swan engagement letter; doctors registered with the Medical Council of Mauritius, consultations reimbursable by insurers. Care network connected: laboratories, pharmacies, radiology and emergency services.

National proposals submitted to governments in Africa and the Indian Ocean. Startup World Cup 2026: winner of the Mauritius regional final and the only Mauritian startup among the 151 finalists of the Grand Finale in San Francisco.

Active in

  • Mauritius
  • Madagascar

Target markets

  • Seychelles
  • Madagascar
  • Angola
  • Cabo Verde
  • Benin
  • Rwanda
  • Kenya
  • Democratic Republic of the Congo
  • South Africa
  • Côte d'Ivoire
  • Nigeria
  • United Arab Emirates
  • United States

Market

AI-augmented primary care software: telemedicine, doctor's workstation (patient records), clinical decision support and AI documentation

Health systems in Africa and the Indian Ocean face doctor shortages, fragmented records and low access to primary care, while insurers need to control claims. AI assistants on WhatsApp and phone, plus documentation that cites guidelines, let one doctor handle more consultations safely. Buyers are insurers, clinics, hospitals, labs, pharmacies and governments, increasingly as white-label distributors under their own brand. TIBOK sells usage-based pricing rather than licences, which lowers adoption barriers in price-sensitive markets.

Addressable market

2025
$137B
2030Not estimated
+11% a year

AI-augmented primary care software (telemedicine, EHR, clinical decision support, AI documentation): ~$137bn to $203bn in 2025, sum of overlapping segments (BCC, MarketsandMarkets, Grand View).

Customers

Insurers (SICOM, Swan), clinics, hospitals, doctors, labs, pharmacies, health centres; white-label distributors (C-Care Madagascar, Médecin à Domicile)

Who signs the cheque

Insurer and provider executives; distributor CEOs; ministries of health for national proposals

Geographies

  • Mauritius
  • Rodrigues
  • Madagascar
  • Africa and Indian Ocean (proposals)

Drivers

  • Doctor shortages and access gaps
  • WhatsApp as the default patient channel
  • Insurers' need for reimbursable, documented consultations

Headwinds

  • Consultation volume still to be proven
  • Country-by-country health regulation
  • Small, self-funded team

Sum of the segments addressed (with overlaps): telemedicine $103bn to $147bn, electronic health records $30bn to $48bn, clinical decision support $2.5bn to $6.4bn, AI medical documentation $1.2bn to $1.7bn, i.e. about $137bn to $203bn in 2025 (BCC Research, MarketsandMarkets, Grand View).

Scalability 8/10. Works in teleconsultation and in the office: a clinic or insurer deploys it with its own doctors, with no TIBOK network to build; multi-LLM software sourced from international guidelines. Obstacles: telemedicine regulation and data hosting, country by country.

Market source: rss.globenewswire.com

Technology

Category

Vertical AI healthcare platform (clinical OS)

AI at the coreGenerative AI / LLMAI agentsLanguage / voice processing

Maturity

  1. R&D
  2. Prototype
  3. Pilot
  4. On the market
  5. Scaling

in market

How it works

Eva, an AI assistant on WhatsApp, phone (SIP) and app, welcomes patients in their language, prepares the doctor's file and coordinates care; My Medical Intelligence drafts documents grounded in 21,000+ authoritative references, signed by the doctor. Labs and radiology connect via HL7 v2 / FHIR R4, and the stack is model-agnostic and hosted per region on AWS.

Moat

Moderate and growing: sourced clinical corpus with doctor sign-off, multilingual agents (Kreol, Malagasy…), insurer reimbursement status and white-label distribution contracts; LLMs themselves are commodity.

Differentiation

Full care-chain OS with pay-per-consultation pricing and white-label workspaces, versus single-purpose teleconsultation apps.

Integration points

  • HL7 v2 / FHIR R4 lab and radiology systems
  • Apple Health, Android Health Connect, Bluetooth devices
  • Insurer claims workflows
  • Pharmacy and lab consultation points
  • Third-party AI medical devices (e.g. dermatology)

Depends on

  • LLM providers (model-agnostic)
  • Medical licensing per country
  • Telecom / WhatsApp channels

Use of AI

MMI: RAG over the guidelines of 15+ international medical authorities, and the EVA conversational agent that gathers information from the patient and directs them.

Product in detail

MMI (My Medical Intelligence). RAG architecture (vector search) over a corpus of guidelines from 15 international authorities and learned societies (WHO, NICE, HAS, CDC, ECDC, USPSTF, ESC, AHA, ADA, KDIGO, IDSA, GOLD, GINA, EASL, ERS), supplemented by ESH, EAS and Choosing Wisely; daily monitoring of publications and human medical validation before integration into the citable corpus.

EVA, a conversational AI agent, gathers information from the patient and directs them; the doctor decides and saves time. Platform connected to the entire chain: teleconsultation, electronic prescription, pharmacies, delivery and payment.

Model-agnostic multi-LLM architecture. a single orchestration layer can use all the major models and picks the best suited to each task, with automatic failover.

Models in use. Anthropic Claude (Sonnet, Opus, Haiku) for reasoning and writing, OpenAI (GPT-4o for vision, GPT-5.4, Whisper for voice, embeddings for RAG) and DeepSeek (chat and reasoner).

Business

Model
Pay-as-you-go usage pricing, no licence; white-label distribution with volume tiers.
Revenue logic
Eva Voice + MMI USD 2.60 per consultation; Eva Chat + MMI USD 1.20; switchboard USD 0.20/min; SilentCheck USD 2.40 voice / USD 1.00 message; −20% from 5,000 and −30% from 20,000 consultations/month.
Go-to-market
Direct in Mauritius plus distributors (C-Care Madagascar live Jan. 2027, Médecin à Domicile) and national proposals to governments.

Next milestones

  1. C-Care Madagascar go-live with measured monthly consultations
  2. Second country distributor or government contract
  3. Close the USD 1.8M seed

Key risks

  • Usage activation still ahead
  • Execution capacity of a small self-funded team
  • Regulatory approval in each new country

Opportunities

5 found in the network

Concrete moves for TIBOK inside the network: who to sell to, sell through, build with or raise from, each with the reasoning, the evidence and the first step.

  • Distribution 1
  • Market entry 1
  • Co-development 2
  • Investors 1

Distribution1

A channel or customer base to reach together

Offer VytalBridge mothers a doctor-backed care layer in Southern Africa

VytalBridge builds a siSwati-first maternal monitoring app and clinical hub but has no doctor network or prescriptions; TIBOK provides teleconsultation, labs and prescriptions under white label. Together they form a complete maternal-care offer for Eswatini and Botswana.

20%confidence

Evidence from the records

  • “'siSwati-first' mobile app with connected vital data, care reminders and consent-based family sharing”
  • “Product in pre-launch (waiting list); no public users or partners.”
  • “chronic care led by the doctor and monitored by Eva”
If it works
A joint maternal-health pilot proposal to an Eswatini or Botswana health authority.
First step
Schedule a call with VytalBridge to map its Doctor Hub to TIBOK's workspace model.

Market entry1

A local partner where they want to go

Power Teramed’s Angolan teleconsultation and corporate health offer as white-label

Teramed holds the local positioning in Angola (corporate health, 24/7 GP teleconsultation, hospital booking) but shows no traction or disclosed technology depth; TIBOK offers exactly the white-label OS model already signed with C-Care. Teramed would become a Portuguese-speaking distributor, opening Angola without TIBOK building a local entity.

40%confidence

Evidence from the records

  • “Baika Corporate (employee health management for companies), 24/7 teleconsultation with general practitioners”
  • “No public evidence of traction found”
  • “distribute it under their own brand, on their own WhatsApp and phone numbers, with one workspace per client (country, language, time zone)”
  • “First white-label distributor contract signed with C-Care Madagascar (19 November 2026)”
If it works
A distributor contract for Angola modelled on C-Care, starting with Baika Corporate clients.
First step
Contact Teramed's CTO via Champions Network with a C-Care-style distributor term sheet and a Portuguese Eva demo.

Co-development2

An integration or joint product

Plug a CE-marked dermatology AI into TIBOK’s photo dermatology

TIBOK already offers dermatology by photo; Legit.Health is a CE-marked medical device scoring skin disease severity from images. Integrating it adds certified decision support to TIBOK's flow and gives Legit.Health distribution in African and Indian Ocean markets it does not cover.

30%confidence

Evidence from the records

  • “dermatology by photo”
  • “CE-marked medical device (ISO 13485)”
  • “Computer vision and deep learning on skin images”
If it works
A per-analysis integration fee model and a joint offer to insurers.
First step
Request Legit.Health's API documentation and pricing for per-image analysis.

Add photo-based anemia screening to SilentCheck and maternal pathways

Anemia is highly prevalent in TIBOK's target markets and usually requires a blood test; Monere screens risk from a smartphone photo of the lower eyelid. Adding it to Eva's pathways extends TIBOK's no-blood-test screening portfolio and gives Monere a real-world deployment channel.

25%confidence

Evidence from the records

  • “SilentCheck (22 questions, no blood test, biological age, built on Framingham, IDRS and SCORED)”
  • “NiADA app (analysis of a smartphone photo of the lower eyelid)”
  • “AI anemia detection solution that assesses risk in a few seconds, without a blood test.”
If it works
A validation pilot in Mauritius or Madagascar comparing photo screening to lab haemoglobin.
First step
Propose to Monere a joint validation protocol using TIBOK's connected labs as reference.

Investors1

A fund whose thesis fits

Bring Axian into the seed as a Madagascar/Indian Ocean strategic

Axian invests $0.05–1.5M at seed/Series A in AI and technology for Africa and the Indian Ocean, with Madagascar in its geographies; TIBOK's C-Care Madagascar launch makes it a natural strategic co-investor in the USD 1.8M seed. No network warm path identified.

25%confidence

Evidence from the records

  • “Technology for African individuals, SMEs and corporates: AI infrastructure, cybersecurity, data sovereignty, digital assets, fintech; 1-5% minority stakes.”
  • “USD 1.8M targeted”
If it works
A strategic ticket plus telecom/distribution access in Madagascar.
First step
Send Axian's investment team the seed memo highlighting the C-Care Madagascar go-live in January 2027.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Investors that fit

Mauritian VC (Managing Partner Fabrice Boulle) backing Mauritian startups able to scale beyond the island at seed.

Mauritian AI primary-care OS with contracts with the two largest Mauritian insurers and a Madagascar expansion: precisely a Mauritian startup scaling beyond the island. Weak points: self-funded, usage still being activated.

60%confidence

Evidence from the records

  • “Startups from Mauritius able to scale beyond the island.”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
  • “expansion to Madagascar under way”
First step
Send Fabrice Boulle the seed deck with Madagascar contract terms and a usage ramp plan.

Mauritian public body awarding non-dilutive grants for ideas, prototypes and proofs of concept through incubator and innovation schemes.

Mauritian AI primary-care OS live in Mauritius and Rodrigues — the only Mauritian network company; health digitalisation aligns with national priorities.

60%confidence

Evidence from the records

  • “"Mauritius","Indian Ocean"”
  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
First step
Apply to the Proof of Concept or Collaborative Research scheme.

Cape Town seed fund backing African startups with continental or global ambition, with Mauritius in scope through IBL Group backing.

Mauritius-based primary-care OS with B2B contracts with the two largest Mauritian insurers and Madagascar expansion, matching 4Di's Mauritius scope and continental-ambition thesis. Risks: self-funded, usage still being activated, so 4Di will probe usage traction.

55%confidence

Evidence from the records

  • “Mauritius”
  • “Seed and post-seed startups with continental or global ambitions”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
Intro path
IBL Group / IBL Link Investments (4Di LP, Mauritius)
First step
Request an intro to Justin Stanford via IBL Link; send the seed deck with the Madagascar roll-out plan and usage metrics.

Pan-African VC ($43M Fund III first close) bridging the late-seed-to-Series A gap, with ≥30% in East, North and Francophone Africa.

Mauritian AI primary-care OS with insurer contracts and Madagascar (Francophone) expansion — Reliance Health/Chefaa pattern.

50%confidence

Evidence from the records

  • “at least 30% in East, North and Francophone Africa”
  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
First step
Send a deck highlighting Francophone expansion.

Madagascar's first impact fund for SMEs and start-ups, sponsored by Investisseurs & Partenaires, providing equity plus governance support.

Mauritian AI primary-care OS with Madagascar expansion under way — Indian Ocean health, a sector gap in Miarakap's portfolio; needs a Malagasy entity or JV.

50%confidence

Evidence from the records

  • “"Madagascar","Indian Ocean"”
  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
First step
Present the Madagascar operating plan.

Nairobi-based Africa VC since 2014 backing bold founders in logistics, mobility, education, healthcare, pharma, carbon removal and applied AI.

Mauritian AI primary-care OS — Penda Health/mPharma logic with software leverage; applied AI.

50%confidence

Evidence from the records

  • “healthcare, pharma, carbon removal and applied AI”
  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
First step
Pitch with insurer distribution and expansion plan.

Mauritius-domiciled pan-African VC ($36.3M debut fund) filling the seed and pre-Series A gap across sectors.

Mauritian AI primary-care OS with insurer contracts and Madagascar expansion — African health at the seed gap; Mauritius domicile aligns.

50%confidence

Evidence from the records

  • “"Seed","Series A"”
  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
First step
Send a seed deck to the Managing Partners.

Nigerian pre-seed and seed VC writing $200K–$400K cheques for ~10% in African tech, with Paystack and 54gene in portfolio.

Mauritian AI primary-care OS with insurer contracts — African healthtech; first institutional cheque would fit the $200–400K range.

45%confidence

Evidence from the records

  • “"HealthTech"”
  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
First step
Share a seed deck with insurer and consultation metrics.

Dubai/Lagos/Cairo pan-African early-stage VC backing contrarian, export-first African founders, with AI as the next leapfrog.

Mauritian AI primary-care OS with contracts from the two largest local insurers and Madagascar expansion. Mirrors P1's Reliance Health bet (insurer-linked care) but is self-funded with usage still ramping up.

45%confidence

Evidence from the records

  • “Contracts signed with the two largest insurers in Mauritius”
  • “HealthTech”
Intro path
Reliance Health (P1 portfolio) is a natural reference for the insurer-linked care model.
First step
Prepare a TIBOK deck contrasting its model with Reliance Health and send to the GPs.

Pan-African early-stage VC with offices in Accra, Cairo and Nairobi, backing fintech, commerce, health and logistics champions.

African primary-care OS connecting doctors, e-prescription and connected pharmacies: complements the mPharma pharmacy thesis in HealthTech. Mauritius/Madagascar are outside 4DX's core hubs and usage volumes are still very low.

40%confidence

Evidence from the records

  • “HealthTech”
  • “connected pharmacies, same-day delivery, insurers”
Intro path
mPharma (4DX portfolio, pharmacy partner logic)
First step
Frame TIBOK as an insurer-and-pharmacy distribution layer and seek an mPharma founder intro.

Pan-African AXIAN Group's CVC, Madagascar-based, taking 1-5% stakes in African AI, cybersecurity, data-sovereignty and fintech startups.

Mauritius primary-care OS expanding to Madagascar (AXIAN's home market), with insurer contracts: Indian Ocean presence and AI-core platform. HealthTech is not a listed sector and usage is still low, so the case rests on Madagascar synergy.

40%confidence

Evidence from the records

  • “Indian Ocean”
  • “Madagascar”
  • “expansion to Madagascar under way”
First step
Pitch the Madagascar roll-out (C-Care contract) as a strategic AXIAN-ecosystem opportunity.

Corporate venture arm of Spanish insurer Mutua Madrileña, investing in health and fintech; led Legit.Health's 2024 round.

Mauritian primary-care OS contracted with the two largest Mauritian insurers — insurer-distributed model.

40%confidence

Evidence from the records

  • “"HealthTech","FinTech"”
  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
Intro path
Founder-to-founder intro via Legit.Health (network portfolio company of Mutua Ventures (Mutua Madrileña)).
First step
Share the insurer B2B case study.

Abuja-based African VC backing founders who remove access barriers and lower the cost of delivering goods and services across Africa.

AI primary-care OS cutting the cost of a consultation, with insurer contracts: health access like mDaaS Global.

40%confidence

Evidence from the records

  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius”
First step
Pitch TIBOK with a sub-Saharan expansion plan.

African VC using tech and capital to leapfrog development, backing seed and Series A ventures that create jobs for women and youth.

Mauritian AI primary-care OS — health access in Africa with insurer distribution.

40%confidence

Evidence from the records

  • “leapfrog development in Africa”
  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
First step
Share access/impact metrics and expansion plans.

French-backed initiative for African tech founders, launching a ~€30M seed fund for about thirty start-ups in frontier ecosystems.

Mauritius AI primary-care OS expanding to Madagascar, a frontier francophone market; French-speaking founder fits the French-backed network. Mauritius itself is not a frontier ecosystem, so the Madagascar roll-out should lead the pitch.

40%confidence

Evidence from the records

  • “Seed capital for African start-ups in frontier ecosystems.”
  • “expansion to Madagascar under way”
First step
Pitch the Madagascar deployment (C-Care) as the use of a ~€0.3M ticket.

New York health-innovation company (since 2011) backing 500+ health founders in Moonshot communities: diagnostics, treatments, type 1 diabetes, Alzheimer's.

AI primary-care OS with insurer contracts in Mauritius: health-access technology from a physician-led team.

35%confidence

Evidence from the records

  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius”
First step
Apply with access-to-care outcome metrics.

Pan-African €110M venture fund (AfricInvest x Cathay Innovation) backing post-revenue startups from seed to growth across fintech, health, edtech, mobility and agri.

Mauritius AI primary-care OS with insurer contracts and Madagascar expansion: HealthTech with regional ambition. Revenue is still early, so the post-revenue bar is the main hurdle.

35%confidence

Evidence from the records

  • “HealthTech”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
  • “expansion to Madagascar under way”
First step
Approach after first quarter of insurer-driven revenue, with Madagascar numbers.

Dubai VC backing founders in high-growth markets across the Middle East and Africa; led BioSapien's pre-Series A.

Mauritius primary-care OS with insurer contracts — African healthtech with regulated distribution, echoing the BioSapien appetite for health; self-funded so a first institutional round would be needed.

35%confidence

Evidence from the records

  • “Africa”
  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
Intro path
Founder-to-founder intro via BioSapien (network portfolio company of Global Ventures).
First step
Share a seed deck with insurer-contract metrics.

Réunion Region financial instrument (€44.8M ERDF, EIF-managed) offering bank loans to local companies, with co-investment under study.

Mauritian AI primary-care OS with a French founder: a Réunion subsidiary could extend the Indian Ocean model into a French/EU territory and unlock FAIRE loans. Requires creating a Réunion entity.

30%confidence

Evidence from the records

  • “Indian Ocean”
  • “Primary care operating system (AI, RAG, EVA agent)”
First step
Assess a Réunion subsidiary and meet BRED or BFCOI.

Spanish healthcare corporate investor whose only known venture deal is dermatology AI company Legit.Health.

Mauritian AI primary-care OS — HealthTech fit; no Spanish deployment yet, so strategic relevance is unproven.

30%confidence

Evidence from the records

  • “"HealthTech"”
  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
Intro path
Founder-to-founder intro via Legit.Health (network portfolio company of Grupo Ribera).
First step
Explore a Spanish-language pilot hypothesis before outreach.

Dakar-based Africa team of Partech ($300M+ second Africa fund) anchoring seed-to-growth rounds, mostly Series A and B.

AI primary-care OS with insurer contracts, a cousin of Partech's Reliance Health bet. Self-funded and early (usage still ramping up), so it is likely pre-Partech; a seed-stage relationship-building fit.

30%confidence

Evidence from the records

  • “Contracts signed with the two largest insurers in Mauritius”
  • “HealthTech”
First step
Introduce TIBOK as an early relationship, with a Series A milestone plan.

AFD Group's private-sector arm investing in African start-ups from Series A, directly and via VC funds (Choose Africa, ~€104M).

Mauritian AI primary-care OS with insurer contracts and Madagascar expansion: strong health-access impact, but self-funded and pre-Series A; Digital Africa is the realistic entry.

30%confidence

Evidence from the records

  • “Primary care operating system (AI, RAG, EVA agent)”
  • “expansion to Madagascar under way”
First step
Approach Digital Africa first with TIBOK's access-to-care metrics.

Xavier Niel's sector-agnostic Paris fund backing tech startups with French founders, in France or abroad, at pre-seed and seed.

Mauritius AI primary-care OS whose physician-founder builds the platform himself — Kima backs French founders abroad; founder nationality is not stated in our record.

30%confidence

Evidence from the records

  • “French founders in France or abroad”
  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
First step
Confirm founder eligibility, then pitch directly.

London/Lagos/Nairobi VC backing African technology founders from seed through Series C.

Mauritian AI primary-care OS with insurer contracts (insurer channel, like Pula in agri-insurance); self-funded and early.

25%confidence

Evidence from the records

  • “Contracts signed with the two largest insurers in Mauritius”
  • “Primary care operating system (AI, RAG, EVA agent)”
First step
Pitch with Madagascar expansion metrics.

Africa growth-stage VC ($205M debut fund backed by Norfund, IFC, BII and 30+ tech founders) investing in startups ready to scale.

Mauritian primary-care OS — too early for now.

25%confidence

Evidence from the records

  • “high-growth African tech startups ready to scale”
  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”

IFC fund-of-funds programme investing $4–6M in emerging-market accelerators and early-stage funds, not directly in startups.

Mauritian AI primary-care OS — health in an emerging market; reachable via IFC-backed African funds.

25%confidence

Evidence from the records

  • “HealthTech”
  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
First step
Identify IFC-backed funds covering the Indian Ocean/Africa.

VC backing early-stage tech in Francophone West and Central Africa; Saviu II backed by Proparco, Axian Group and Triple Jump.

AI primary-care OS from francophone Mauritius, expanding to Madagascar; strong access-to-care story, but the Indian Ocean is outside Saviu's West/Central focus.

25%confidence

Evidence from the records

  • “Primary care operating system (AI, RAG, EVA agent)”
  • “expansion to Madagascar under way”
First step
Pitch only alongside a concrete West/Central African deployment.

Norwegian DFI whose Scalable Enterprises team invests in growing Sub-Saharan African businesses directly and via funds like Norrsken22.

Mauritian primary-care OS — SSA health; too early, sector outside focus.

20%confidence

Evidence from the records

  • “Scalable enterprises drive growth and jobs”
  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
First step
Approach Norfund-backed funds.

Pan-African Verod-Kepple JV ($60M first fund) writing $1M-$3M into up to 21 growth-stage companies, Series A and B.

Health operating system with insurer contracts: a vertical ERP-like platform, but self-funded and not in a listed country.

20%confidence

Evidence from the records

  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Self-funded”
First step
Revisit once TIBOK operates in a listed country.

AfDB-EIB initiative that backed African VC funds (Partech Africa, TLcom TIDE, Janngo, Seedstars Africa); now fully deployed.

AI primary care with insurer distribution and affordable access aligns with HealthTech and inclusion themes. Boost Africa is fully deployed, so the real target is its investee funds (e.g., Partech Africa, TLcom TIDE Africa).

20%confidence

Evidence from the records

  • “HealthTech”
  • “Entrepreneurship and innovation for jobs and inclusion, with focus on youth, women and affordable products.”
First step
Pitch Partech Africa or TLcom TIDE Africa, citing affordability metrics.

Dutch development bank FMO's venture facility, co-investing in tech companies that make goods and services affordable for underserved communities.

Affordable AI primary care with insurer distribution: inclusion impact, but health is not a listed sector and no lead investor yet.

15%confidence

Evidence from the records

  • “Primary care operating system (AI, RAG, EVA agent)”
  • “insurers”
First step
Revisit once a seed lead is secured.

UK development finance institution backing African and Asian tech and telecoms, directly and via funds, from US$1M tickets.

AI primary care with insurer distribution in Mauritius and Madagascar: access-to-health fit, but self-funded and below BII's Series A threshold.

15%confidence

Evidence from the records

  • “Primary care operating system (AI, RAG, EVA agent)”
  • “expansion to Madagascar under way”
First step
Target BII-backed fund managers now; BII directly at Series A.

Cape Town VC (Knife Fund III, $50M) taking South African B2B technology global with $3–7M milestone-based Series A/B cheques.

Mauritian primary-care OS — African B2B health software; far earlier than Knife's stage.

15%confidence

Evidence from the records

  • “"AI & software"”
  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”

Majority black-owned South African VC targeting a US$50M fund for post-revenue AI and fintech startups with product-market fit.

AI health platform with insurer contracts: AI fit, but health is not a listed sector and revenue is very early.

15%confidence

Evidence from the records

  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
First step
Low priority until revenue traction.

LGT/Liechtenstein-backed impact growth investor writing $10–20M cheques into proven African companies such as Moniepoint and Sun King.

Mauritian primary-care OS — impact health but far too early.

10%confidence

Evidence from the records

  • “impact”
  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
First step
Long-term relationship only.

Bpifrance: France's public investment bank, funding French startups from pre-seed to growth through grants, loans and equity.

French-founded but Mauritius-incorporated: TIBOK is not eligible without a French entity. Possible only through a French subsidiary for a European roll-out.

10%confidence

Evidence from the records

  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Mauritius”
First step
Consider only if a French subsidiary is created.

Investment analysis

6.0B

Grade B

Rank 10 of 151

Disruption6.0/10
Business model5.0/10
Market9.0/10
Risk(lower is better)7.0/10

Global score = mean of disruption, model, market and (11 − risk). Last updated 22 Nov 2026.

Global market and top-tier scalability, model validated by two insurers, but usage still low: a case to follow closely; investment will be triggered when the contracts translate into consultation volume and recurring revenue.

Disruption

6/10

AI-augmented primary care operating system (RAG sourced from 15 learned societies, EVA agent, multi-LLM) connecting the entire care chain: ambitious integration, in a known category, telehealth.

Business model

5/10

Contracts signed with the two largest insurers in Mauritius: real B2B validation and a distribution channel. But the number of consultations remains very low and no revenue is published: the model is signed, not yet proven by usage.

Market

9/10

Global TAM of about $137bn to $203bn in 2025: TIBOK is not only telemedicine ($103bn to $147bn) but also the doctor's in-office workstation (patient records $30bn to $48bn), clinical decision support ($2.5bn to $6.4bn) and AI documentation ($1.2bn to $1.7bn). Highly scalable: in in-person mode, a clinic or insurer deploys it with its own doctors; first expansion under way in Madagascar.

Risk

7/10

Lower is better

Team of 5 people, which reduces dependence on the founder alone; remaining risks are health and clinical AI regulation, the lack of outside funding, still-low usage and data declared by the company.

Strengths

  • Contracts signed with the two largest Mauritian insurers
  • Hybrid platform (teleconsultation and office) on a global TAM of $137bn to $203bn, already exported to Madagascar

Risks

  • Very few consultations: adoption still to be proven
  • Self-funded, small team, Madagascar expansion to be funded

Funding

Undisclosed, no funding
  1. 2026 (en cours)

    seed (in progress)USD 1.8M targeted

    not disclosed

  2. 2026 (en cours)

    seed (self-reported on VC4A)EUR 500K–1M at EUR 3.5M pre-money

    not disclosed

Amount used in the study. Self-funded; the $1.8M target (seed in preparation) is not counted.

Note. Self-funded to date; round in preparation (target USD 1.8M according to the pitch, EUR 500K–1M on the VC4A profile)

Team

  • Dr Stéphane Bach

    Founder & CEO

    Public health medical specialist (30+ years of experience), he designs and codes the TIBOK platform himself.

Sources

Identification confidence
high
Founding year: 2025 (high confidence)
Founding year provided by the founder (Digital Data Solution Ltd)
  1. 1tibok.mu/
  2. 2vc4a.com/ventures/digital-data-solution-ltd/

From the open study Startup World Cup 2026 by TIBOK, based on public sources, verified in November 2026. Scores are an analyst's judgment on an explicit grid, not the jury's.

Wall

Wall

Want to talk to the team behind TIBOK?

Sign in to message

No posts yet